{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T18:33:19Z","timestamp":1755801199298,"version":"3.44.0"},"reference-count":30,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ugeskr L\u00e6ger"],"abstract":"<jats:p>Alcohol is the primary cause of approximately 70-80% of liver diseases in Denmark. Stopping alcohol consumption before symptoms appear can prevent many liver diseases. Effective alcohol treatment is also cost-effective and can significantly improve liver function. This review suggests that healthcare professionals should identify and treat alcohol problems early, using both pharmacological and non-pharmacological therapies. Challenges include a lack of patient insight and the need for better-integrated treatment programmes.<\/jats:p>","DOI":"10.61409\/v12240915","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T06:16:15Z","timestamp":1749536175000},"page":"1-8","source":"Crossref","is-referenced-by-count":0,"title":["Alcohol treatment for patients with alcohol-related liver disease"],"prefix":"10.61409","author":[{"given":"Elise Jonasson","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Andrup","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette Munk","family":"Lauridsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lea Ladegaard","family":"Gr\u00f8nkj\u00e6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"40208","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"ref0","unstructured":"Sundhedsstyrelsen. Antallet af personer med problematisk alkoholforbrug vil fremover blive m\u00e5lt ud fra CAGE-C-metoden, 2023. https:\/\/www.sst.dk\/da\/nyheder\/2023\/Antallet-af-personer-med-problematisk-alkoholforbrug-vil-fremover-blive-maalt-ud-fra-CAGE-C-metoden (05.02.25)"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Arab JP, Addolorato G, Mathurin P, Thursz MR. Alcohol-associated liver disease: integrated management with alcohol use disorder. Clin Gastroenterol Hepatol. 2023;21(8):2124-2134. https:\/\/doi.org\/10.1016\/j.cgh.2023.02.017","DOI":"10.1016\/j.cgh.2023.02.017"},{"key":"ref2","unstructured":"DeMuckadell OBS, Hauns\u00f8 S, Vilstrup H. Medicinsk Kompendium. Munksgaard. 2019."},{"key":"ref3","unstructured":"Askgaard G, Kraglund F, Kann AE et al. Epidemiologi for alkoholrelateret leversygdom. Ugeskr L\u00e6ger. 2021;183:V11200893. https:\/\/ugeskriftet.dk\/videnskab\/epidemiologi-alkoholrelateret-leversygdom"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Haque LY, Zuluaga P, Muga R, Fuster D. Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action. Addict Sci Clin Pract. 2024;19(1):19. https:\/\/doi.org\/10.1186\/s13722-024-00448-8","DOI":"10.1186\/s13722-024-00448-8"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Khan A, Tansel A, White DL et al. Efficacy of psychosocial interventions in inducing and maintaining alcohol abstinence in patients with chronic liver disease: a systematic review. Clin Gastroenterol Hepatol. 2016;14(2):191-202.e1-4;quiz e20. https:\/\/doi.org\/10.1016\/j.cgh.2015.07.047","DOI":"10.1016\/j.cgh.2015.07.047"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Addolorato G, Mirijello A, Barrio P, Gual A. Treatment of alcohol use disorders in patients with alcoholic liver disease. J Hepatol. 2016;65(3):618-30. https:\/\/doi.org\/10.1016\/j.jhep.2016.04.029","DOI":"10.1016\/j.jhep.2016.04.029"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Vannier AGL, Shay JES, Fomin V et al. Incidence and progression of alcohol-associated liver disease after medical therapy for alcohol use disorder. JAMA Netw Open. 2022;5(5):e2213014. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.13014","DOI":"10.1001\/jamanetworkopen.2022.13014"},{"key":"ref8","unstructured":"Grandahl MG, Nielsen AS, Tolstrup J et al. Behandling af alkoholproblemer i Danmark. Atlas Den L\u00e6gefaglige T\u00e6nketank. 2022."},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Addolorato G, Vassallo GA, Mirijello A, Gasbarrini A. Diagnosis and management of alcohol use disorder in patients with liver disease: lights and shadows. Neurotherapeutics. 2020;17(1):127-141. https:\/\/doi.org\/10.1007\/s13311-019-00802-8","DOI":"10.1007\/s13311-019-00802-8"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Nielsen AS, Askgaard G, Thiele M. Treatment of alcohol use disorder in patients with liver disease. Curr Opin Pharmacol. 2022;62:145-151. https:\/\/doi.org\/10.1016\/j.coph.2021.11.012","DOI":"10.1016\/j.coph.2021.11.012"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Zierau F, Hardt F, Henriksen JH et al. Validation of a self-administered modified CAGE test (CAGE-C) in a somatic hospital ward: comparison with biochemical markers. Scand J Clin Lab Invest. 2005;65(7):615-22. https:\/\/doi.org\/10.1080\/00365510500333445","DOI":"10.1080\/00365510500333445"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Gr\u00fcner Nielsen D, Andersen K, Nielsen AS et al. Consistency between self-reported alcohol consumption and biological markers among patients with alcohol use disorder - a systematic review. Neurosci Biobehav Rev. 2021;124:370-385. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.02.006","DOI":"10.1016\/j.neubiorev.2021.02.006"},{"key":"ref13","unstructured":"Helander A, Hansson T. National harmonization of the alcohol biomarker PEth. Lakartidningen. 2013;110(39-40):1747-8."},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Skr\u00e5stad RB, Aamo TO, Andreassen TN et al. Quantifying alcohol consumption in the general population by analysing phosphatidylethanol concentrations in whole blood: results from 24,574 subjects included in the HUNT4 Study. Alcohol Alcohol. 2023;58(3):258-265. https:\/\/doi.org\/10.1093\/alcalc\/agad015","DOI":"10.1093\/alcalc\/agad015"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Helander A, Hermansson U, Beck O. Dose-Response characteristics of the alcohol biomarker phosphatidylethanol (PEth) - a study of outpatients in treatment for reduced drinking. Alcohol and Alcohol. 2019;54(6):567-573. https:\/\/doi.org\/10.1093\/alcalc\/agz064","DOI":"10.1093\/alcalc\/agz064"},{"key":"ref16","unstructured":"Lindvig K, Krag A, Thiele M. Tidlig opsporing af alkoholrelateret leversygdom. Ugeskr L\u00e6ger. 2021;183:V12200947. https:\/\/ugeskriftet.dk\/videnskab\/tidlig-opsporing-af-alkoholrelateret-leversygdom"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Mellinger JL, Fernandez AC, Winder GS. Management of alcohol use disorder in patients with chronic liver disease. Hepatol Commun. 2023;7(7):e00145. https:\/\/doi.org\/0.1097\/HC9.0000000000000145","DOI":"10.1097\/HC9.0000000000000145"},{"key":"ref18","unstructured":"Becker U, Andersen K, Christiansen R. Litteraturgennemgang af evidens vedr\u00f8rende alkoholbehandling. Enheden for Klinisk Alkoholforskning, 2023. https:\/\/www.sst.dk\/-\/media\/Udgivelser\/2024\/Alkoholbehandling\/Litteraturgennemgang-evidens-vedroerende-alkoholbehandling.ashx?sc_lang=da&hash=5DE8F078C2536D99FE5E939CA027D71D (05.02.25)"},{"key":"ref19","unstructured":"Sundhedsstyrelsen. National klinisk retningslinje for behandling af alkoholafh\u00e6ngighed, 2018. https:\/\/www.sst.dk\/da\/udgivelser\/2018\/~\/media\/CA9BFF045305498EAD4B537AC518DF4D.ashx (05.02.25)"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Thursz M, Gual A, Lackner C et al. EASL clinical practice guidelines: management of alcohol-related liver disease. Journal of Hepatology. 2018;69(1):154-181. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.018","DOI":"10.1016\/j.jhep.2018.03.018"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Verheul R, Lehert P, Geerlings PJ et al. Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients. Psychopharmacology (Berl). 2005;178(2-3):167-73. https:\/\/doi.org\/10.1007\/s00213-004-1991-7","DOI":"10.1007\/s00213-004-1991-7"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Monterosso JR, Flannery BA, Pettinati HM et al. Predicting treatment response to naltrexone: the influence of craving and family history. Am J Addict. 2001;10(3):258-68. https:\/\/doi.org\/10.1080\/105504901750532148","DOI":"10.1080\/105504901750532148"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"R\u00f6sner S, Hackl-Herrwerth A, Leucht S et al. Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev. 2010;(12):CD001867. https:\/\/doi.org\/10.1002\/14651858.CD001867.pub3","DOI":"10.1002\/14651858.CD001867.pub3"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"DiMartini AF, Leggio L, Singal AK. Barriers to the management of alcohol use disorder and alcohol-associated liver disease: strategies to implement integrated care models. Lancet Gastroenterol Hepatol. 2022;7(2):186-195. https:\/\/doi.org\/10.1016\/S2468-1253(21)00191-6","DOI":"10.1016\/S2468-1253(21)00191-6"},{"key":"ref25","unstructured":"May C, Nielsen AS, Bilberg R. Barriers to Treatment for Alcohol Dependence. Journal of Drug and Alcohol Research. 2019;(8)236083."},{"key":"ref26","unstructured":"Sundhedsstyrelsen. National klinisk retningslinje for udredning og behandling af samtidig alkoholafh\u00e6ngighed og psykisk lidelse, 2024. https:\/\/www.sst.dk\/da\/udgivelser\/2016\/nkr-for-udredning-og-behandling-af-samtidig-alkoholafhaengighed-og-psykisk-lidelse (04.02.25)"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Crum RM, Mojtabai R, Lazareck S et al. A prospective assessment of reports of drinking to self-medicate mood symptoms with the incidence and persistence of alcohol dependence. JAMA Psychiatry. 2013;70(7):718-26. https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.1098","DOI":"10.1001\/jamapsychiatry.2013.1098"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"\u00d8stberg N, Jacobsen BG, Lauridsen MM, Gr\u00f8nkj\u00e6r LL. Mental health, quality of life, and stigmatization in danish patients with liver disease. Int J Environ Res Public Health. 2023;20(8):5497. https:\/\/doi.org\/10.3390\/ijerph20085497","DOI":"10.3390\/ijerph20085497"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Andr\u00e9asson S, Finn SW, Bakshi AS. Barriers to treatment for alcohol dependence: a qualitative study. Addiction Science & Clinical Practice. 2013(1):A5. https:\/\/doi.org\/10.1186\/1940-0640-8-S1-A5","DOI":"10.1186\/1940-0640-8-S1-A5"}],"container-title":["Ugeskrift for L\u00e6ger"],"original-title":[],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T13:19:57Z","timestamp":1755695997000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/videnskab\/V12240915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":30,"URL":"https:\/\/doi.org\/10.61409\/v12240915","relation":{},"ISSN":["0041-5782","1603-6824"],"issn-type":[{"type":"print","value":"0041-5782"},{"type":"electronic","value":"1603-6824"}],"subject":[],"published":{"date-parts":[[2025,5,26]]}}}